跳至主要内容
临床试验/JPRN-UMIN000004925
JPRN-UMIN000004925已完成未知

The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor - The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor

Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 70 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. type 1 diabetes mellitus 2. Patients who take both ACE inhibitor and ARB 3. Ptients who have allergy to the study drugs 4. Severe hypertension (180/110 mmHg or higher) 5. Pregnant women, women who want to be pregnant 6. Patients taking cyclosporine 7. Sever liver dysfunction (GOT>80 IU/L, GPT>80 IU/L), renal dysfunction (Cr>1.5(male), 1.4 (female) mg/dl)

研究者

发起方
Department of Internal Medicine, School of Medicine, Keio University

相似试验